Form D · Other Health Care

INTEGRATED BIOPHARMA INC

Hillside, NJ · CIK 0001016504

Offering snapshot reported Jul 11, 2012 · SEC filing

Reported sold
$5.35M
Offering amount: $5.35M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jun 27, 2012
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 11, 2012Initial$5,350,000No comparison1SEC filing
Mar 7, 2008PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Debt, Security to be acquired, Other
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-181032
Secured convertible note, in the original principal amount of $5,350,000, convertible into common stock of the Issuer at a conversion price of $0.65, subject to customary adjustments.
Secured convertible promissory note and the underlying shares of common stock issuable upon conversion thereof.

Source: Form D, filed Jul 11, 2012. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Robert Canarick Director
Carl De Santis Director
Christina Kay Director, Executive
E. Gerald Kay Director, Executive
Dina L. Masi Executive
William Milmoe Director
Riva Sheppard Director, Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
225 Long Avenue
Hillside, NJ, 07205